Ticker
NRIXCompany Name
NURIX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
9/30/2025 | $ 440.6M | $ 82.35M | $ 358.25M |
6/30/2025 | $ 515.33M | $ 75.61M | $ 439.72M |
3/31/2025 | $ 563.7M | $ 89.99M | $ 473.71M |
12/31/2024 | $ 619.39M | $ 95.85M | $ 523.53M |
9/30/2024 | $ 456.04M | $ 86.3M | $ 369.75M |
6/30/2024 | $ 450.22M | $ 80.78M | $ 369.44M |
3/31/2024 | $ 250.97M | $ 87.62M | $ 163.35M |
12/31/2023 | $ 295.5M | $ 86.96M | $ 208.54M |
9/30/2023 | $ 267.95M | $ 61.49M | $ 206.46M |
6/30/2023 | $ 290.01M | $ 72.26M | $ 217.75M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for NURIX THERAPEUTICS INC is calculated as follows: AssetsC [ $ 298.43M ] - LiabilitesC [ $ 44.54M ]
(=) Working Capital [ $ 253.9M ]
Minimum
Mar 31, 2024
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 2.79K |
---|---|
min | $ -457.39M |
max | $ 607.04M |
average | $ 96.42M |
median | $ 32.11M |
std | $ 173.65M |